AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/coms2/summary_0286-12855838_ITM" title="Facts and information about Abbott Laboratories announces US 510(k) clearance and international launch of Architect Stat CK-MB test that assists in heart attack detection.">Abbott Laboratories announces US 510(k) clearance and international launch of Architect Stat CK-MB test that assists in heart attack detection.</a>
Close
Set up an RSS feed that alerts you when new articles from Asia Africa Intelligence Wire are available.
Frequently asked questions about RSS feeds
Abbott Laboratories announces US 510(k) clearance and international launch of Architect Stat CK-MB test that assists in heart attack detection.
(From Chemical Business NewsBase - Press Release)
Abbott Laboratories announced a 510(k) clearance with the US Food and Drug Administration (FDA) for a Creatine Kinase-MB (CK-MB) test for use on Abbott's Architect i2000SR Immunoassay System and Architect ci8200 Immunochemistry System. A cardiac marker used to assist in the diagnosis of a heart attack, monitoring …
Related articles from newspapers, magazines, journals, and more
